Transgene (EPA:TNG) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
French (CAC) Biotech Industry Analysis
UpdatedJan 20, 2022
DataAggregated Company Financials
Companies38
- 7D-10.0%
- 3M-22.9%
- 1Y-36.2%
- YTD-20.3%
Over the last 7 days, the Biotech industry has dropped 10%, driven by a decline by Valneva of 19%. Meanwhile, Acticor Biotech SAS actually outperformed within the industry, gaining 41% in the last week. However, the industry is down 36% over the past year.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 21 Jan 2022 | €5.6b | €932.4m | -€677,940,801.00 | 3.2x |
| Sun, 19 Dec 2021 | €7.3b | €925.9m | -€681,351,448.00 | 3.1x |
| Tue, 16 Nov 2021 | €6.9b | €926.2m | -€682,868,763.00 | 2.4x |
| Thu, 14 Oct 2021 | €6.1b | €891.9m | -€679,082,032.00 | 2.9x |
| Sat, 11 Sep 2021 | €7.8b | €878.8m | -€620,422,159.12 | 2.7x |
| Mon, 09 Aug 2021 | €6.5b | €899.6m | -€600,532,159.12 | 2.7x |
| Sun, 02 May 2021 | €7.2b | €882.0m | -€570,006,611.92 | 3.1x |
| Wed, 03 Feb 2021 | €7.1b | €911.8m | -€514,619,691.42 | 22.3x |
| Sat, 07 Nov 2020 | €4.7b | €737.3m | -€578,081,678.94 | 8.7x |
| Fri, 31 Jul 2020 | €4.1b | €624.3m | -€569,407,653.44 | 29.7x |
| Mon, 04 May 2020 | €5.0b | €608.4m | -€585,561,414.96 | 18.8x |
| Thu, 06 Feb 2020 | €4.4b | €548.6m | -€625,688,103.67 | 16.8x |
| Sun, 10 Nov 2019 | €3.4b | €544.8m | -€607,268,613.10 | 56.4x |
| Sat, 03 Aug 2019 | €4.3b | €547.0m | -€661,534,274.60 | 38.9x |
| Tue, 07 May 2019 | €5.0b | €561.3m | -€612,527,196.00 | 24x |
| Fri, 08 Feb 2019 | €4.1b | €558.2m | -€577,409,059.20 | 22.9x |
PE Ratio
22.9x
Current Industry PE: There are only 3 profitable companies in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 19% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the French Biotech industry?
| Biotech | -10.01% | |
Industry PE: Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 19.3x. However analysts are expecting annual earnings growth of 53%, which is lower than the prior year's growth of 158% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 53% over the next 5 years. However this is lower than its past earnings growth rate of 158% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TNG Transgene | €2.65 | 5.0% +€12.2m | 0.4% | PS28.8x | |
| ALACT Acticor Biotech SAS | €6.54 | 21.3% +€12.1m | n/a | PB16.8x | |
| IVA Inventiva | €11.20 | 1.8% +€8.2m | -28.0% | PS81.1x | |
| ALINT IntegraGen | €1.40 | 19.5% +€1.5m | -33.4% | PS1x | |
| ALGEN genOway Société anonyme | €4.59 | 2.7% +€1.1m | 36.9% | PS2.3x |